Allogene (ALLO) PT Raised to $66 at Goldman Sachs
Tweet
Share
E-mailGet Alerts ALLO Hot Sheet
Price: $2.07 --0%
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 9 | New: 6
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 9 | New: 6
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter raised the price target on Allogene (NASDAQ: ALLO) to $66.00 (from $45.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- Unicycive Therapeutics (UNCY) PT Lowered to $25 at Guggenheim
- Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
